Form D/A — NewLimit, Inc.
0001977037-25-000001 · filed Jan 7, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $72,245,500
- Reported amount sold
- $72,245,500
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- NewLimit, Inc.
- CIK
- 1977037
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 901 Gateway Boulevard
South San Francisco, California 94080 - Phone
- 415-603-9539
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Michael Polansky · Executive OfficerSouth San Francisco, California Find on LinkedIn ↗
-
Brian Armstrong · DirectorSouth San Francisco, California Find on LinkedIn ↗
-
Blake Byers · DirectorSouth San Francisco, California Find on LinkedIn ↗
-
Zavain Dar · DirectorSouth San Francisco, California Find on LinkedIn ↗
-
Jacob Kimmel · DirectorSouth San Francisco, California Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗